ArticleBMC pulmonary medicine2024

A prospective, open-label, randomized clinical trial to evaluate the efficacy and safety of remimazolam in patients undergoing EBUS-TBNA: REST trial design.

Hee Yun Seol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.